Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    "Afibrinogenemia"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Conditions: Afibrinogenemia;   Hypofibrinogenemia;   Fibrinogen Deficiency
Interventions: Biological: Fibrinogen Concentrate, Human (FCH);   Biological: Cryoprecipitate
2 Not yet recruiting Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenaemia
Condition: Congenital Afibrinogenaemia
Intervention: Biological: Human Plasma-Derived Fibrinogen Concentrate
3 Recruiting Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency
Conditions: Hypofibrinogenemia, Congenital;   Afibrinogenemia, Congenital
Intervention: Drug: biological: human fibrinogen concentrate
4 Recruiting Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Conditions: Congenital Afibrinogenemia;   Congenital Hypofibrinogenemia
Intervention: Biological: BT524 (fibrinogen concentrate from human plasma)
5 Recruiting Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
Conditions: Congenital Fibrinogen Deficiency;   Afibrinogenemia
Interventions: Biological: Octafibrin  - (Factor I concentrate);   Biological: Haemocomplettan/Riastap (Factor I concentrate)
6 Completed
Has Results
Human Fibrinogen - Pharmacokinetics
Condition: Fibrinogen Deficiency
Intervention: Biological: Human Fibrinogen Concentrate
7 Recruiting Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery
Condition: Congenital Fibrinogen Deficiency
Intervention: Drug: Octafibrin
8 Recruiting Haemocomplettan® P During Elective Complex Cardiac Surgery
Condition: Fibrinogen Deficiency in Complex Cardiac Surgery
Interventions: Drug: Haemocomplettan® P;   Drug: Human albumin (Placebo)

Indicates status has not been verified in more than two years